Artículos de revistas
Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes
Date
2010Registration in:
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.45, n.9, p.4180-4187, 2010
0223-5234
10.1016/j.ejmech.2010.06.010
Author
PEREIRA, Jose Clayston Melo
CARREGARO, Vanessa
COSTA, Diego Luis
SILVA, Joao Santana da
CUNHA, Fernando Q.
FRANCO, Douglas Wagner
Institutions
Abstract
The complexes trans-[Ru(NO)(NH(3))(4)L](X)(3) (X = BF(4)(-), PF(6)(-) or Cl(-) and L = N-heterocyclic ligands, P (OEt)(3), SO(3)(-2)), and [Ru(NO)Hedta)] were shown to exhibit IC(50pro) in the range of 36 (L = imN) to 5000 mu M (L = imC). The inhibitory effects of trans-[Ru(NO)(NH(3))(4)imN](BF(4))(3) and of the Angeli`s salt on the growth of the intramacrophage amastigote form studied were found to be similar while the trans-[Ru(NH(3))(4)imN(H(2)O)](2+) complex was found not to exhibit any substantial antiamastigote effect. The trans-[Ru(NO)(NH(3))(4)imN](BF(4))(3) compound, administered (500 nmol kg(-1) day(-1)) in BALB/c mice infected with Leishmania major, was found to exhibit a 98% inhibition on the parasite growth. Furthermore, this complex proved to be at least 66 times more efficient than glucantime in in vivo experiments. (C) 2010 Elsevier Masson SAS. All rights reserved.